ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.96 | 0.61 | 0.08 | 0.00 | 0.00 |
Long Term Debt-Equity Ratio | 0.43 | 0.15 | 0.05 | 0.00 | 0.00 |
Current Ratio | 0.96 | 1.15 | 2.54 | 2.86 | 2.73 |
Fixed Assets | 0.73 | 1.05 | 1.43 | 1.63 | 1.57 |
Inventory | 12.05 | 19.68 | 18.05 | 16.25 | 17.02 |
Debtors | 7.16 | 6.51 | 7.31 | 9.67 | 8.71 |
Interest Cover Ratio | 1.55 | 6.73 | 22.00 | 151.34 | 414.72 |
PBIDTM (%) | 30.64 | 31.97 | 38.97 | 42.20 | 38.55 |
PBITM (%) | 19.97 | 25.27 | 34.15 | 37.97 | 35.16 |
PBDTM (%) | 17.71 | 28.22 | 37.42 | 41.95 | 38.47 |
CPM (%) | 15.21 | 26.31 | 34.52 | 38.55 | 35.01 |
APATM (%) | 4.54 | 19.61 | 29.69 | 34.32 | 31.62 |
ROCE (%) | 6.83 | 9.97 | 19.94 | 25.68 | 26.48 |
RONW (%) | 3.07 | 12.63 | 19.23 | 23.88 | 24.39 |